PAR27 WITHDRAWAL OF ROFECOXIB FROMTHE MARKET; THERAPEUTIC AND ECONOMIC IMPLICATION FOR THE NETHERLANDS
Abstract
Authors
C Boersma P Pechlivanoglou PB Van den Berg SN Shakele M Postma
C Boersma P Pechlivanoglou PB Van den Berg SN Shakele M Postma
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now